IL62870A - Modulators of the immune system and methods for the preparation thereof - Google Patents

Modulators of the immune system and methods for the preparation thereof

Info

Publication number
IL62870A
IL62870A IL62870A IL6287081A IL62870A IL 62870 A IL62870 A IL 62870A IL 62870 A IL62870 A IL 62870A IL 6287081 A IL6287081 A IL 6287081A IL 62870 A IL62870 A IL 62870A
Authority
IL
Israel
Prior art keywords
modulators
effects
suppressor
human
immunity system
Prior art date
Application number
IL62870A
Other languages
English (en)
Other versions
IL62870A0 (en
Original Assignee
Arthur Gottlieb A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthur Gottlieb A filed Critical Arthur Gottlieb A
Publication of IL62870A0 publication Critical patent/IL62870A0/xx
Publication of IL62870A publication Critical patent/IL62870A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Developing For Electrophotography (AREA)
  • Dry Development In Electrophotography (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL62870A 1980-05-14 1981-05-14 Modulators of the immune system and methods for the preparation thereof IL62870A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14973780A 1980-05-14 1980-05-14
US25688681A 1981-05-06 1981-05-06

Publications (2)

Publication Number Publication Date
IL62870A0 IL62870A0 (en) 1981-07-31
IL62870A true IL62870A (en) 1985-03-31

Family

ID=26846987

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62870A IL62870A (en) 1980-05-14 1981-05-14 Modulators of the immune system and methods for the preparation thereof

Country Status (11)

Country Link
EP (1) EP0042064B1 (fr)
JP (1) JPH0453848B2 (fr)
AU (1) AU555652B2 (fr)
CA (1) CA1163194A (fr)
DE (1) DE3176443D1 (fr)
DK (1) DK214481A (fr)
FI (1) FI78483C (fr)
IE (1) IE53572B1 (fr)
IL (1) IL62870A (fr)
NO (1) NO156516C (fr)
WO (1) WO1981003279A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
US4616079A (en) * 1984-08-24 1986-10-07 Imreg, Inc. Immunoamplifiers and processes for the extraction thereof
CA1286989C (fr) * 1985-12-26 1991-07-30 A. Arthur Gottlieb Immunoamplificateurs et composes apparentes
EP0247538A3 (fr) * 1986-05-28 1989-08-30 Imreg, Inc. Immunosuppresseur et son procédé d'extraction
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment
ES2106784T3 (es) * 1990-07-02 1997-11-16 Nat Jewish Ct Immun & Respirat Factor de transferencia y metodos de uso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4180627A (en) * 1978-08-17 1979-12-25 The United States Of America As Represented By The Secretary Of Agriculture Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener

Also Published As

Publication number Publication date
IE811075L (en) 1981-11-14
JPS57500611A (fr) 1982-04-08
AU7057881A (en) 1981-11-19
EP0042064A3 (en) 1983-01-19
FI811473L (fi) 1981-11-15
NO811626L (no) 1981-11-16
AU555652B2 (en) 1986-10-02
CA1163194A (fr) 1984-03-06
DE3176443D1 (en) 1987-10-22
WO1981003279A1 (fr) 1981-11-26
NO156516B (no) 1987-06-29
FI78483B (fi) 1989-04-28
EP0042064B1 (fr) 1987-09-16
JPH0453848B2 (fr) 1992-08-27
DK214481A (da) 1981-11-15
IE53572B1 (en) 1988-12-21
EP0042064A2 (fr) 1981-12-23
FI78483C (fi) 1989-08-10
IL62870A0 (en) 1981-07-31
NO156516C (no) 1987-10-07

Similar Documents

Publication Publication Date Title
DE3375759D1 (en) Process for purifying modulators of the immune system
Fay Behavioral audiogram for the goldfish.
NL192914B (nl) Werkwijze voor de bereiding van een antioxidant preparaat en daarmee verkregen preparaat.
NO156553C (no) Fremgangsmaate for fremstilling av en vandig farmasoeytisk opploesning inneholdende ubidecarenon.
MX169403B (es) Conjunto de accion retardada
AU6804987A (en) Method for treating plasma and products thereof
IL68350A0 (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
ATE179333T1 (de) Immunotherapeutische zubereitung
IL62870A (en) Modulators of the immune system and methods for the preparation thereof
NL190399B (nl) Ijzer-bevattend eiwitmateriaal, bereiding daarvan, en farmaceutisch preparaat voor de behandeling van sideropene anaemie.
WO1998039034A3 (fr) Utilisation de preparations contenant des anticorps anti-cd44 pour traiter certaines tumeurs et supprimer les reactions immunitaires
MY117323A (en) Method of scavenging free radicals using orange extract
AU3390584A (en) Preparation for rehydrating monogastric animals,including human beings,suffering from diarrhoea and use thereof
EP0136768A3 (fr) Composition et méthode de traitement de lésions cutanées
ZA792939B (en) Membrane stabilizing compounds having b-receptor blocking activity,their preparation,method for treatment of arrhythmic conditions,and pharmaceutical preparations containing same
NL7902311A (nl) Werkwijze en inrichting voor de compressie van de dynamiek van ontvangen teruggestrooide signalen.
NL8301963A (nl) Nieuwe derivaten van 4-hydroxychinoline-3-carbonzuur die op de 2-plaats zijn gesubstitueerd, werkwijzen voor hun bereiding, hun toepassing als geneesmiddel en preparaten die ze bevatten en de verkregen tussenprodukten.
NL7901941A (nl) Tegengif voor behandeling van dieren en pluimvee tegen acute vergiftiging door fosfororganische bestrijdings- middelen.
DE3373978D1 (en) Composition for the care or treatment of the human skin
AU5277979A (en) Medium for separation of human blood leukocytes
IE832277L (en) 6-anilino-5, 8-quinoxalinediones.
AU556929B2 (en) Rodent bait
SE8303729D0 (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
NL188833C (nl) Preparaat op basis van water bevattende dispersies van bolvormige deeltjes.
IT8248451A0 (it) N-/-(3-amminopropil) amminobutil/2,2-diidrossietanammide come immuno stimolante ed intermedio per la produzione di sostanza carcinostatiche, e procedimento per la sua preparazione